DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for GFP assay are 19

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_3437	Obatoclax	Anticancer	Leukemia | Myelofibrosis | Hodgkin's Lymphoma | Mantle-Cell Lymphoma	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	Investigational	22910914
DrugRepV_3438	Gemcitabine	Antineoplastic and Immunomodulating Agents	Ovarian cancer | Non-small cell lung cance | Adenocarcinoma of the pancreas	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	Approved	22910914
DrugRepV_3439	Saliphenylhalamide	NA	NA	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	NA	22910914
DrugRepV_3440	Carfilzomib	Antineoplastic and Immunomodulating Agents	Multiple myeloma	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	Approved	22910914
DrugRepV_3441	Bortezomib	Antineoplastic and Immunomodulating Agents	Multiple myeloma and mantle cell lymphoma	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	Approved	22910914
DrugRepV_3442	NVP-AUY922	NA	NA	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	NA	22910914
DrugRepV_3443	Alvespimycin	NA	Cancer	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	Investigational	22910914
DrugRepV_3444	Tanespimycin	NA	Cancer	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	Investigational	22910914
DrugRepV_3445	Obatoclax	Anticancer	Leukemia | Myelofibrosis | Hodgkin's Lymphoma | Mantle-Cell Lymphoma	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	Investigational	22910914
DrugRepV_3446	Gemcitabine	Antineoplastic and Immunomodulating Agents	Ovarian cancer | Non-small cell lung cance | Adenocarcinoma of the pancreas	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	Approved	22910914
DrugRepV_3447	Saliphenylhalamide	NA	NA	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	NA	22910914
DrugRepV_3448	Carfilzomib	Antineoplastic and Immunomodulating Agents	Multiple myeloma	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	Approved	22910914
DrugRepV_3449	Bortezomib	Antineoplastic and Immunomodulating Agents	Multiple myeloma and mantle cell lymphoma	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	Approved	22910914
DrugRepV_3450	NVP-AUY922	NA	NA	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	NA	22910914
DrugRepV_3451	Alvespimycin	NA	Cancer	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	Investigational	22910914
DrugRepV_3452	Tanespimycin	NA	Cancer	Influenza virus	PR8-GFP		GFP assay	Decrease (50 %)	Investigational	22910914
DrugRepV_3734	OSU-03012	Anticancer	Brain cancer	Nipah virus	NA	NA	GFP assay	Decrease (50 %)	NA	25986249
DrugRepV_3735	OSU-03012	Anticancer	Brain cancer	Ebola virus	NA	NA	GFP assay	Decrease (50 %)	NA	25986249
DrugRepV_3736	OSU-03012	Anticancer	Brain cancer	Marburg virus	NA	NA	GFP assay	Decrease (50 %)	NA	25986249